This Week in Virology9 Syys 2023

TWiV 1042: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses China's health authorities fighting surge in cases of Mpox unknown origin, analysis of seasonal variation of antibiotic prescribing for respiratory tract diagnoses in primary care practices, prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza, comparison of bivalent and monovalent mRNA vaccine boosters, optimal duration of systemic corticosteroids in COVID-19 treatment, acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization, temporal changes in fecal microbiota of patients infected with COVID-19, and long-term survival after intensive care for COVID-19.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

China's health authorities fight surge in cases of unknown origin (BMJ)
Analysis of seasonal variation of antibiotic prescribing for respiratory tract diagnoses (ASHE)
Prevalence and outcomes of co-infection between SARS-CoV-2 and influenza (IJID)
Comparison of bivalent and monovalent mRNA vaccine boosters (CID)
Optimal duration of systemic corticosteroids in COVID-19 treatment (OFID)
Acute blood biomarker profiles predict cognitive deficits after COVID-19 hospitalization (Nature)
Temporal changes in fecal microbiota of patients infected with COVID-19 (BMC)
Long-term survival after intensive care for COVID-19 (AIC)
Contribute to our Floating Doctors fundraiser at PWB
Letters read on TWiV 1042
Dr. Griffin's COVID treatment summary (pdf)
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(1370)

TWiV 1335: TldR, bacterial hot rods and nullifying norovirus

TWiV explains research showing how temperate phages enhance bacterial host fitness via RNA-guided flagellar remodelling, and that IgA antibody is necessary and sufficient to prevent norovirus infectio...

28 Kesä 1h 55min

TWiV 1334: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss the global economic burden of infectious disease, restoring trust in vaccinology, the Legionnaires outbreak in Harlem, new ...

27 Kesä 31min

TWiV 1334: Clinical update with Dr. Daniel Griffin

27 Kesä 31min

TWiV 1333: STING like a nanoparticle, float like HIV

TWiV explains research showing how HIV-1 signalling remodels nuclear pores to licence infection, and development of STING agonist nanoparticles to enable coordinated mucosal-systemic immunity for dura...

21 Kesä 1h 54min

TWiV Special: Ebola virus and Andes virus with John Dye

Vincent travels to ASM Microbe in Washington DC to speak with John Dye of the United States Army Medical Research Institute of Infectious Diseases about the recent outbreaks of Bundibugyo ebolavirus i...

20 Kesä 57min

TWiV 1332: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello express concern about vaccine policy and ACIP, scaling back of the CDC's role in global public health, shingles vaccine and dement...

20 Kesä 54min

TWiV 1331: A drug for cervical cancer

TWiV explains research showing that dairy cows are infected with low doses of influenza A(H5N1) and do not transmit efficiently to other animals, and covalent inhibitors of human papillomavirus type 1...

14 Kesä 1h 58min

TWiV 1330: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello opine on the recent executive order on the routine childhood vaccination schedule, the Ebola outbreak in the Congo and Uganda inclu...

13 Kesä 1h 11min